Objective: The aim of the present study was to implement a nurse telephone education programme for patients with recently diagnosed rheumatoid arthritis (RA) that promotes shared decision-making and a treat-to-target approach. Conclusion: This preliminary project successfully implemented an educational programme that included a nurse-facilitated, RA-specific, telephone call and toolkit.
| INTRODUCTION
Rheumatoid arthritis (RA) is a burdensome chronic inflammatory disease that affects 0.5-1.0% of European and North American populations (Silman & Pearson, 2002) . The disease is characterized by inflammatory arthritis and extra-articular manifestations including vasculitis, interstitial lung disease and cardiovascular disease (Smolen, Aletaha, & McInnes, 2016) . Recent data suggest that patients with RA have a higher risk of death from cardiovascular, respiratory, malignant and infectious causes compared with the general population (Listing et al., 2015; Ogdie et al., 2017) . Societal costs associated with RA are estimated at greater than $20 billion annually in the United States (Birnbaum et al., 2010) .
The treat-to-target (T2T) concept involves a set of internationally accepted recommendations and principles for the clinical management of RA, including shared decision-making with patients to achieve remission and low disease activity . The principles were adapted from the approaches used in managing diabetes, hypertension and hyperlipidaemia, where therapy is adjusted until reaching a prespecified target, such as achieving a specific glycated haemoglobin goal for diabetes or blood pressure goal for hypertension (Smolen et al., 2010) . A T2T approach in RA involves setting a disease activity target, regularly measuring disease activity using validated instruments, and timely adjustment of medication doses and therapies to reach the goal (Aletaha & Smolen, 2018) . Recent data confirm that a T2T approach results in better outcomes than a conventional approach to managing RA (Stoffer et al., 2016) . This approach is especially important in early RA, where guidelines have suggested aggressive approaches to treatment (Singh et al., 2016) .
A successful T2T approach requires shared decision-making by patients and healthcare providers. This involves patient participation in selecting a disease activity target, discussing how disease activity will be measured, creating a therapy plan and deciding on how frequently re-evaluation will occur .
Patients need appropriate RA education, self-management skills, selfefficacy and belief in their ability to manage their RA successfully, or they will be unable to partner effectively in making shared decisions (Voshaar, Nota, van de Laar, & van den Bemt, 2015) . Patient knowledge and satisfaction with care have been shown to improve medication adherence (Viller et al., 1999) . However, evidence suggests that patients may not routinely have the education they need to partner effectively with the providers of their RA care (Dragoi et al., 2013; Meesters, Vliet Vlieland, Hill, & Ndosi, 2009) . Educational efforts must focus on interventions that are feasible, available to all RA patients as part of their rheumatology care, and sustainable.
The purpose of the present pilot project was to design and implement a pragmatic nurse telephone education programme for patients with recently diagnosed RA that promotes shared decision-making and a T2T approach.
| METHODS
The project was conducted in the rheumatology and clinical immunol- provider requests to include patients. Subjects were excluded if they were non-English speaking, did not verbally agree to speak to a nurse or were unable to be contacted by telephone after several attempts.
We created a standardized form for the nurses to use during their calls to patients. The form included a script for patient verbal consent on one side. The other side of the form included patient demographics, key teaching points for the nurse to review with the patient, and a free-text box for the nurses to document observations about the call and to record quotes from patients.
The project was designed to be a pragmatic intervention, and therefore the nurses made the telephone calls within the context of their usual activities. Ultimately, the project was assigned to one triage nurse (S.F.). The main discussion points of the calls included evaluating patients' understanding of an RA diagnosis and their understanding that RA is a chronic condition, discussing functional improvements and the usefulness of tracking symptoms, knowing when to call the clinic and the importance of keeping follow-up appointments. We The work was reviewed by our ethics board, the UVM Committees on Human Research, and was considered exempt research.
Therefore, no written patient consent was required. Participation in the telephone calls was considered as verbal consent by our ethics board.
| RESULTS
Twenty-eight patients were called during the project timeframe. The median number of call attempts was 1, with a range of 1-4. Two patients (7%) were unreachable after four attempts and were excluded.
Twenty-six patients participated in the nurse calls (Table 1) Qualitative analysis of the nurse notes from patient calls revealed three important themes (Table 2 ). It was common for patients to be uncertain or overwhelmed by their diagnosis, reporting to the nurse: "This is all so new to me" and "I'm not convinced there is anything wrong". Patients also reported being fearful of an RA diagnosis or of taking medications. They overwhelmingly reported that the nurse calls were helpful, with comments such as: "I truly appreciate the call. I feel like you are looking out for me" and "It makes me feel really connected to my providers. I feel really confident in my care". Ten patients (38.5%) indicated to the nurse that they would begin tracking their RA symptoms as a result of the call.
Nineteen patients (73%) were adherent to their follow-up visit. Of the seven patients who were non-adherent to their follow-up visit, six lived more than 17.8 miles from the clinic.
| DISCUSSION
We successfully implemented a nurse-facilitated patient education programme for rheumatology patients with newly diagnosed RA.
Based on the success of the programme, this intervention was incorporated into the daily responsibilities of the nursing staff. The lowcost toolkit and use of telephone education increased the likelihood of sustainability and generalizability. We found that patients did not fully understand the implications of a diagnosis of RA, and would benefit from more education about their disease and treatment plans, and how to partner successfully with providers in their care.
Some patients were in denial about, or fearful of, their diagnosis of RA, potentially leading to non-adherence or missed clinic appointments. Additionally, some lacked sufficient knowledge about their disease or treatment plans to partner successfully in their care. Patients overwhelmingly reported that calls were helpful, with many agreeing to behaviour changes, such as symptom tracking, medication adherence and maintaining follow-up appointments.
This project was consistent with the overarching principles of recommended patient education for inflammatory arthritis care (Zangi et al., 2015) , and also with recent quality indicators for RA.
The European Musculoskeletal Conditions Surveillance and Information Network (EUMUSC.NET) created a specific quality indicator for RA patient education (Mahmood, Lesuis, van Tuyl, van Riel, & Landewe, 2015) . Specifically, the second Health Care Quality Indicator for RA (HCQI RA 2) states: "If a patient is newly diagnosed with RA, then, he or she should be given individually tailored education by relevant health professionals about the natural history, treatment, and self-management of the disease within 3 months". This project represented our initial attempt to provide this education systematically, with the goal of supporting shared decision-making and a treat-totarget approach. Some patients were prescribed more than one RA medication. The majority of patients on a csDMARD were prescribed methotrexate. All patients prescribed a biologic were prescribed a TNF inhibitor. • "This is all so new to me"
• Patient did not attend scheduled appointment because he "didn't want to deal with it" satisfaction and self-management (Candelas et al., 2016) . The integration of nurses, clinical pharmacists and other healthcare professionals into rheumatology practices may ultimately improve outcomes for the increasingly complex patients cared for by rheumatologists.
There were several limitations to this project. We did not anticipate that several newly diagnosed patients would be non-English speaking. These patients are likely to be among those in greatest need of disease education, so translation and culturally competent education should be explored as part of any future efforts. The volume of patients with newly diagnosed RA was lower than expected, making recruitment an unexpected challenge. Additionally, we were unable to obtain sufficient reports from our electronic health record to identify newly diagnosed RA patients easily. These two factors contributed to our lower-than-expected sample size.
| CONCLUSION
This pilot project successfully implemented an educational programme that included a nurse-facilitated, RA-specific telephone call and toolkit.
The strength of our approach was in designing our educational programme with the goal of long-term sustainability and generalizability.
This programme could be a model for similar educational efforts by nurses at other clinics.
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